Bottom line
How much do FHLC and ETHSX overlap?
63% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 56.6% of FHLC's assets and 60.3% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 42), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and ETHSX have in common
| Holding | % of FHLC | % of ETHSX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 12.47% | 12.47% |
| Johnson & Johnson | 8.93% | 6.45% | 6.45% |
| AbbVie Inc | 6.42% | 6.46% | 6.42% |
| UnitedHealth Group Inc | 5.44% | 5.49% | 5.44% |
| Merck & Co Inc | 4.66% | 5.08% | 4.66% |
| Thermo Fisher Scientific Inc | 3.09% | 2.79% | 2.79% |
| Abbott Laboratories | 2.66% | 1.65% | 1.65% |
| Gilead Sciences Inc | 2.34% | 3.34% | 2.34% |
| Bristol-Myers Squibb Co | 1.93% | 4.25% | 1.93% |
| Intuitive Surgical Inc | 1.82% | 2.72% | 1.82% |
| Vertex Pharmaceuticals Inc | 1.76% | 3.38% | 1.76% |
| Stryker Corp | 1.62% | 2.21% | 1.62% |
| Medtronic PLC | 1.59% | 1.80% | 1.59% |
| Boston Scientific Corp | 1.00% | 2.18% | 1.00% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Amgen Inc — 3.00%
- Pfizer Inc — 2.06%
- CVS Health Corp — 1.92%
- Danaher Corp — 1.80%
- McKesson Corp — 1.52%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- HCA Healthcare Inc — 0.91%
- Cencora Inc — 0.83%
- Cardinal Health Inc — 0.78%
Only in ETHSX
- AstraZeneca PLC — 6.24%
- Roche Holding AG — 5.44%
- Sanofi SA — 2.95%
- Lonza Group AG — 1.77%
- Novo Nordisk A/S — 1.71%
- Novartis AG — 1.65%
- Argenx SE — 1.61%
- Royalty Pharma PLC — 1.58%
- Neurocrine Biosciences Inc — 1.41%
- Mettler-Toledo International Inc — 1.36%
- Straumann Holding AG — 1.34%
Asset mix
| Asset type | FHLC | ETHSX |
|---|---|---|
| Stocks | 99.7% | 99.4% |
| Cash & short-term funds | 0.2% | 0.3% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | FHLC | ETHSX |
|---|---|---|
| US | 96.5% | 69.4% |
| CH | 0.1% | 10.2% |
| GB | 0.5% | 7.8% |
| FR | — | 3.2% |
| DK | — | 2.9% |
| IE | 2.2% | 1.8% |
| NL | 0.1% | 2.0% |
| AU | — | 0.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FHLC and ETHSX overlap?
What stocks do FHLC and ETHSX have in common?
Should I own both FHLC and ETHSX?
Which holds more stocks, FHLC or ETHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.